Standard operating procedure for renewal of micro-, small- or medium-sized-enterprise status

Standard operating procedure for assignment of micro-, small- or medium-sized-enterprise status

Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Sun, sitagliptin,metformin hydrochloride, Date of authorisation: 31/03/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Sunitinib Accord, sunitinib, Date of authorisation: 11/02/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 12, Status: Authorised

UPD registration guide for UI and API users

Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 25, Status: Authorised